SCHEMBL7769044

SCHEMBL7769044

Oc1[nH]c(O)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.47
▸ MAPT P10636 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ POLB P06746 3/20 0.47
▸ TDP1 Q9NUW8 3/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 6/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ GPR3 P46089 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.41
▸ IDE P14735 1/20 0.41
▸ MPI P34949 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ APBA1 Q02410 1/20 0.41
▸ IMPDH2 P12268 1/20 0.41
▸ IMPDH1 P20839 1/20 0.41
▸ CYP1A2 P05177 1/20 0.39
▸ LMNA P02545 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28833399 0.81 AHR (0.43) IDO1MAPTRAB9APOLBTDP1
SCHEMBL49099 0.69 ALDH1A1 (0.59) IDO1MAPTRAB9APOLBTDP1
SCHEMBL444380 0.69 MAPT (0.39) IDO1MAPTRAB9APOLBTDP1
SCHEMBL526630 0.67 IDO1 (0.56) IDO1MAPTRAB9APOLBTDP1
SCHEMBL13698928 0.67 ALDH1A1 (0.64) MAPTPOLBTDP1MEN1KMT2A
SCHEMBL2468887 0.65 POLB (0.48) IDO1MAPTRAB9APOLBTDP1
SCHEMBL888293 0.65 PADI4 (0.55) IDO1MAPTRAB9APOLBTDP1
SCHEMBL7206760 0.65 IDO1 (0.53) IDO1MAPTRAB9APOLBTDP1
SCHEMBL29638 0.65 IDO1 (1.00) IDO1MAPTRAB9APOLBTDP1
SCHEMBL5712104 0.65 ALDH1A1 (0.50) IDO1MAPTTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333400-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-10-30 — — US disclosed
US-20010020345-A1 Gasoline additive for direct injection gasoline engine NIPPON MITSUBISHI OIL CORPORATION 2001-09-13 — — US disclosed
EP-1122295-A1 GASOLINE ADDITIVE FOR DIRECT-INJECTION GASOLINE ENGINE Nippon Mitsubishi Oil Corporation (JP) 2001-08-08 — — EP disclosed
US-5928393-A ESTERIFIED, ALKOXYLATED TERTIARY AMINE COMPOUND; DETERGENT ANTISLUDGE/ANTIDEPOSIT AGENT FOR INTERNAL COMBUSTION ENGINES NIPPON OIL CO., LTD. (JP) 1999-07-27 — — US disclosed
EP-0819753-A1 Fuel additive NIPPON OIL CO. LTD. (JP) 1998-01-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333400-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE SNRPE, SNRPB2, DDX21 IDO1 4575/4885MAPT 4458/4885RAB9A 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback